Delivery Order SPE2DE24D0021-SPE2D626F06ME
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,940 on January 8, 2026, for BinaxNOW COVID-19 antigen testing kits to support the Defense Department's Medical Supply Chain. The contract is a fixed-price delivery order with economic price adjustment provisions, with a completion deadline of January 15, 2026. As a child contract, this award represents an individual order issued under a larger indefinite delivery vehicle or blanket purchase agreement. No set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 by the Department of Defense's Medical Supply Chain for the provision of BinaxNOW COVID-19 antigen testing kits. The contract was awarded on October 30, 2025, with an ultimate completion date of November 6, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a fixed-price contract with economic price adjustment provisions and was issued without set-aside designations,...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,159.12 on November 4, 2025, for the provision of BinaxNow COVID antigen testing kits to support the Department of Defense Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. Performance will be executed from Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- The Department of Defense Medical Supply Chain awarded a $2,897.80 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. for BinaxNow COVID-19 40-count test kits on January 12, 2026. This contract represents a child award under a larger indefinite delivery vehicle and carries an ultimate completion date of January 20, 2026, indicating a near-term fulfillment requirement. No set-aside designation was applied to this procurement, reflecting open...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. has been awarded a $4.3K delivery order for BinaxNOW COVID-19 antigen testing kits under a fixed-price contract with economic price adjustment provisions. The award was issued on January 7, 2026, with an ultimate completion date of January 14, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, indicating open competition, and is funded by the Department of Defense's Medical Supply Chain...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,617.00 to Fisher Scientific Company L.L.C. on August 26, 2025, for the procurement of BinaxNOW COVID-19 antigen tests (12 tests per 2-test case). This fixed-price contract with economic price adjustment provisions is categorized as a child contract and does not utilize a set-aside designation, indicating open competition among qualified vendors. The place of performance is Pittsburgh, Pennsylvania, with...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F06MEDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,960 on January 13, 2026, for the provision of BinaxNOW COVID-19 antigen testing kits to support the Department of Defense's Medical Supply Chain. This contract represents a child delivery order issued under a larger procurement vehicle and utilizes a fixed-price contract structure with economic price adjustment provisions. The performance location is Pittsburgh, Pennsylvania, and the contract is scheduled for completion by January 21, 2026. No small business set-aside was applied to this procurement, indicating it was awarded through open competition. Fisher Scientific, a major federal supplier of laboratory equipment and medical products registered in the System for Award Management since 2001, has extensive experience fulfilling medical supply requirements across multiple federal agencies. The company's established relationship with the Department of Defense's Medical Supply Chain reflects its demonstrated capability to deliver specialized diagnostic equipment and supplies on an expedited basis. The relatively short performance period and modest contract value are consistent with routine consumable medical supply procurements supporting federal healthcare and diagnostic operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/12/26 |